Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.660
-0.040 (-2.35%)
At close: Apr 28, 2026, 4:00 PM EDT
1.720
+0.060 (3.61%)
After-hours: Apr 28, 2026, 7:53 PM EDT
Ocugen Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Ocugen stock have an average target of 9.75, with a low estimate of 7.00 and a high estimate of 12. The average target predicts an increase of 487.35% from the current stock price of 1.66.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 25, 2026.
Analyst Ratings
The average analyst rating for Ocugen stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +321.69% | Mar 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +502.41% | Mar 25, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +622.89% | Mar 17, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +502.41% | Mar 11, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +321.69% | Mar 5, 2026 |
Financial Forecast
Revenue This Year
2.20M
from 4.41M
Decreased by -50.08%
Revenue Next Year
40.06M
from 2.20M
Increased by 1,718.38%
EPS This Year
-0.23
from -0.23
EPS Next Year
-0.20
from -0.23
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 6.3M | 167.5M | ||||||
| Avg | 2.2M | 40.1M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 42.8% | 7,504.2% | ||||||
| Avg | -50.1% | 1,718.4% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -0.20 | 0.13 | ||||
| Avg | -0.23 | -0.20 | ||||
| Low | -0.25 | -0.36 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.